Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07654166

Tissue Adhesive Versus Sutures in Oral Biopsy Closure

Excisional biopsies are commonly performed in the oral mucosa, and proper wound closure and hemostasis are critical for the success of the surgical procedure. Suturing remains the gold standard for closing surgical incisions; however, it has several drawbacks, including being time-consuming and requiring technical skill for proper placement. In addition, access to posterior areas of the oral cavity can be challenging. Suturing may also cause patient discomfort during needle penetration of tissues and can serve as a potential pathway for microbial contamination. Therefore, this randomized controlled clinical trial aims to evaluate one of the latest tissue adhesives from the cyanoacrylate group (PeriAcryl 90 HV) compared to conventional surgical sutures (Nylon 4-0) for wound closure following oral excisional biopsies. A total of 28 patients with oral fibroma will be randomly assigned to either the tissue adhesive group or the suture group (14 patients per group).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Damascus University ,Department of Oral Medicine, Faculty of Dentistry

Damascus, Mazzh, Syria

Location status: Recruiting

Location contact

Nour J Ibrahim, DDS _ MSc student

SUB_INVESTIGATOR

Nour J Ibrahim, DDS_ MSc student

CONTACT

[email protected]

+963959800513

Omar H Hamadah, Professor

CONTACT

[email protected]

+963940705554

About this study

Appropriate closure of the surgical wound is essential for achieving successful surgical outcomes and optimal wound healing. Although sutures are the most commonly used method for closing wounds in the oral mucosa, they may cause discomfort to patients, particularly in the buccal and labial mucosa. Furthermore, sutures require a second clinical visit for removal. These limitations highlight the clinical need for an alternative to conventional sutures that is easy to apply, does not require removal, and minimizes patient discomfort. This study will compare tissue adhesive (PeriAcryl 90 HV) versus surgical sutures (Nylon 4-0) for wound closure after oral fibroma excision in a randomized controlled trial design.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Patients clinically diagnosed with oral fibroma located on the

labial mucosa (lip) or buccal mucosa (cheek).

  • Lesion requires excisional biopsy.
  • Lesion size greater than 3 mm and less than 3 cm in

greatest diameter.

Exclusion criteria

  • Pregnant or breastfeeding women.
  • Patients taking anticoagulant medications (blood thinners).
  • Patients with infectious diseases such as hepatitis, HIV, etc.
  • Patients taking immunosuppressants.
  • Patients with uncontrolled diabetes mellitus.
  • Patients taking medications that affect bleeding and wound healing.

Treatment and study plan

Tissue adhesive (PeriAcryl 90 HV)

Device

After excisional biopsy of oral fibroma and achieving hemostasis by applying pressure with saline-soaked gauze, the wound surface will be gently dried. PeriAcryl 90 HV (high viscosity butyl cyanoacrylate) will be applied directly using a pipette to cover the entire wound surface . A second layer will be applied 10-15 seconds after the first layer to ensure adequate thickness and durability. The adhesive will polymerize upon contact with moist tissue within approximately 10-20 seconds.

Surgical suture (Nylon 4-0)

Device

After excisional biopsy of oral fibroma and achieving hemostasis, the wound margins will be approximated using tissue forceps. Interrupted sutures using Nylon 4-0 will be placed to close the wound. Sutures will be removed on day 7 postoperatively.

Primary outcomes

  1. Early Wound Healing Score (EHS)

    Time frame: Assessed at day 7 and day 14 postoperatively.

    Wound healing will be assessed using the Early Wound Healing Score (EHS), a validated clinical index that evaluates three parameters: clinical signs of re-epithelialization (CSR, scored 0-6), clinical signs of haemostasis (CSH, scored 0-2), and clinical signs of inflammation (CSI, scored 0-2). The total score ranges from 0 (worst healing) to 10 (excellent healing).

  2. Operative time (minutes)

    Time frame: Measured intraoperatively using a stopwatch.

    The time measured from the start of wound closure (immediately after excisional biopsy and hemostasis) to the complete wound closure. For the tissue adhesive group, this ends when the second layer polymerizes. For the suture group, this ends after the last interrupted suture is placed.

Secondary outcomes

  1. Postoperative pain measured by Visual Analogue Scale (VAS)

    Time frame: Measured at 24 hours, 3 days, and 7 days postoperatively.

    Pain intensity will be assessed using a 10-cm Visual Analogue Scale (VAS), where 0 cm represents "no pain" and 10 cm represents "the worst possible pain". Patients will be asked to mark their pain level on the scale at each time point.

Study contacts

Contact information is provided by the study sponsor or research team.

Nour J Ibrahim, DDS _ MSc student

CONTACT

[email protected]

+963959800513

Omar H Hamadah, Professor

CONTACT

[email protected]

+963940705554

Sponsors and collaborators

Lead sponsor

Damascus University

Other

Registry information

Official study title

Comparison of Tissue Adhesive and Surgical Sutures for Wound Closure After Oral Excisional Biopsies: A Randomized Controlled Clinical Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jun 17, 2026
Registry last updated
Jun 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.